[ACRX] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -18.19%
YoY- 4.26%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 1,862 1,368 608 377 1,487 3,366 15,428 -29.67%
PBT -8,375 -8,930 -12,731 -12,458 -13,013 -11,438 5,841 -
Tax 796 931 1,212 -2,601 -3,233 -36 772 0.51%
NP -8,375 -8,930 -12,731 -12,458 -13,013 -11,402 5,069 -
Tax Rate - - - - - - -13.22% -
Total Cost 10,237 10,298 13,339 12,835 14,500 14,768 10,359 -0.19%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -449.79 -652.78 -2,093.91 -3,304.51 -875.12 -338.74 32.86 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.40 -2.03 -3.20 -4.15 -5.61 -5.03 2.20 -
EPS Diluted -1.40 -2.03 -3.20 -4.15 -5.61 -5.03 2.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.